一个切割的METTL3增强了METTL3-WTAP相互作用和乳腺癌进展
Chaojun Yan1, Jingjing Xiong1, Zirui Zhou1
1Department of Thyroid and Breast Surgery, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
eLife
|August 17, 2023
概括
一种新的METTL3,METTL3a的分裂形式,对于乳腺癌中的RNA甲基化至关重要. 这一发现揭示了一个新的METTL3a-mTOR信号通路,可以用于癌症治疗.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- *由甲基转移酶复合体 (MTC) 调节的RNA N6-甲基氨酸 (m6A) 甲基化与乳腺癌有关.
- *MTC的精确监管机制,包括METTL3-METTL14异构体和WTAP,尚未完全理解.
研究的目的:
- * 确定乳腺癌中m6A甲基化新型调节机制.
- * 研究一种新发现的METTL3分裂形式,称为METTL3a,在MTC功能和乳腺瘤发生中的作用.
主要方法:
- * METTL3a.的识别和特征.
- *使用m6A测序研究METTL3a在MTC复合体形成和RNA m6A沉积中的作用.
- *分析METTL3a对癌细胞增殖和mTOR信号传递的影响.
- * 检查METTL3a和mTOR信号之间的反循环,包括蛋白质体降解.
主要成果:
- * 一种新型的分裂形式,METTL3a (METTL3的239-580残留物) 已被确定,被发现对METTL3-WTAP相互作用和MTC组装至关重要.
- *METTL3a对全球m6ARNA沉积至关重要,并促进乳腺癌细胞的增殖.
- *METTL3a通过通过m6A抑制TMEM127表达来调解mTOR激活.
- *METTL3裂变由蛋白质酶以mTOR-依赖的方式调节,建立一个积极的反循环.
结论:
- *METTL3a是MTC的关键组成部分,对于其在RNA m6A甲基化中的功能至关重要.
- *METTL3a-mTOR信号轴代表了乳腺癌治疗的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


